Incyte Corp at Evercore ISI HealthCONx Conference Transcript
Great. Good morning, everyone. This is Maneka Mirchandaney from the Evercore ISI biotech team. I'm really pleased to be here with Incyte. We've got Hervé, Christiana, Mike and Christine from the team. Thank you all for being here.
Questions & Answers
And maybe to start, can you just give us a quick sense for where Incyte is now? And what the key areas of focus for the company are going to be over the next couple of years?
Okay. Well, good morning. Happy to be here to speak about that. I mean the way we look at -- I mean, it has been a fairly busy year. It was a little bit of a paradox because we were dealing with the COVID situation. And then at the same time, we had like 3 new approvals during the year. We have been in a fairly busy phase of the -- in the life of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
